Strato阶段接收
Stratophase, a specialist in real-time chemical and biochemical measurement and detection, has started the new year in style by securing £2.5m follow-on funding from existing investor East Hill Management. Commenting on the funding, Dr Richard Williams, CEO of Stratophase said, "These are exciting times for Stratophase. We are initiating a SpectroSens Early Access Programme in key markets and are actively seeking strategic partner organisations with the intention of leveraging this widely applicable technology into multiple end markets". The additional investment will enable the company to roll out their SpectroSens real-time monitoring technology in target markets. The roll out will be supported by recruitment of key staff and a move to larger premises.
Spectrosens光学微芯片平台技术集思广益电讯产业证明科学集思广益,目前正在开发用于过程测量和生物检测等多项应用,目标应用迄今包括实时联机监控制药业(小分子和生物药厂)、生物燃料生产、生物检测安全安全及军事防御诊断和护理点诊断等。Spectrosens系统目前正由数大组织试用,其中包括一顶级多国制药公司和联合王国军方
Stratostem和spectrosen系统详情请访问http://www.stratophase.com/.